TREMFYA (guselkumab) Patient Assistance Program

Don’t let the high cost of brand specialty psoriasis biologics stand between you and the
treatment you need. We help eligible patients access Tremfya (guselkumab) for as little
as $69.95 per month through the manufacturer's Patient Assistance Program.

HIPAA Compliant

BBB Accredited

Secure Website

Key ​Takeaways:

What is Tremfya Prescription Assistance Program?

The Tremfya Prescription Assistance Program is a manufacturer-sponsored initiative that provides Tremfya at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for patients with psoriasis, PsA, or IBD who are uninsured or underinsured, as well as Medicare Part D beneficiaries.

Navigating the program on your own means dealing with eligibility verification, prescriber coordination, TB screening, prior-authorization documentation, specialty pharmacy logistics, and renewal deadlines.

AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates
handle every step of your enrollment, from initial application through ongoing refill coordination and
annual re-certification — so you focus on your health, not paperwork.

Pharmacy Price Comparison

Pharmacy(With Coupon)PrIce (30-Day)*You Save W/ Us
Walgreens (per dose)~$14,500.00Save ~$14,430/dose
CVS Pharmacy (per dose)

~$15,000.00

Save ~$14,930/dose

Walmart (per dose)

~$13,500.00

Save ~$13,430/dose
Costco (per dose)~$13,200.00

Save ~$13,130/dose

GoodRx Best Price

~$13,000.00

Save ~$12,930/dose

*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

Why choose us For Your Tremfya Prescription Program?

The Patient Assistance Program is free to apply for and provides Tremfya at no medication cost if approved. But the process involves detailed applications, prescriber coordination, TB screening documentation, specialty pharmacy logistics, and ongoing renewal management. Our $69.95/month service covers full advocacy.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.

We Advocate

Our specialists help gather documentation, complete applications, and coordinate with program providers.

Receive Medication

Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.

Discount Coupons vs. Patient Assistance Programs

Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Vidaza:

Limitations of Coupons

  • Prices fluctuate — savings aren’t guaranteed month-to-month

  • Copay accumulators may prevent savings from counting toward your deductible

  • Coupon cards expire and require constant renewal

  • Still $13,000–$15,000 per month even
    with the best discount

  • Cannot be used with Medicare, Medicaid, or government insurance

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price

  • No expiration — continuous access as long as you qualify
  •  Medication supplied directly through the assistance program

  • We manage all paperwork, refills, and annual renewals

  • Medicare Part D patients accepted

DO YOU QUALIFY?

Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to
contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Tremfya assistance.

Understanding Tremfya:

Tremfya (guselkumab) is a biologic medicine in the IL-23 inhibitor class used to treat moderate-to- severe plaque psoriasis (in adults and pediatric patients 6 and older), active psoriatic arthritis, moderately to severely active ulcerative colitis, and moderately to severely active Crohn’s disease. It is
given as a subcutaneous injection at Week 0 and Week 4, then every 8 weeks for maintenance (psoriasis/PsA) or following indication-specific dosing schedules.


How It Works:

Plaque psoriasis, psoriatic arthritis, and inflammatory bowel disease are all driven in part by overactive IL-23 signaling, which drives Th17 immune cells to produce inflammatory cytokines (including IL-17) that cause skin lesions, joint inflammation, and intestinal inflammation. IL-23 is a master regulator of this inflammatory cascade. Tremfya is a monoclonal antibody that selectively binds to the p19 subunit of IL-23 and blocks it from interacting with its receptor. By neutralizing IL-23 specifically (without affecting IL-12, which is also blocked by older drugs like Stelara), Tremfya provides targeted suppression of the Th17 inflammatory
response. This selective targeting can produce strong skin clearance and joint improvement with a generally favorable safety profile.


Form and Use:

Tremfya is given as a 100 mg subcutaneous injection. For psoriasis: at Week 0, Week 4, then every 8 weeks. For psoriatic arthritis: same schedule, or 200 mg loading then maintenance. For ulcerative colitis and Crohn’s: IV induction followed by SC maintenance every 4 or 8 weeks. The injection can be
self-administered at home after training.

Generic Availability:

There is no biosimilar version of Tremfya in the U.S. as of 2026. Other IL-23 inhibitors are FDA- approved (risankizumab/Skyrizi, tildrakizumab/Ilumya) for psoriasis. Other biologic options for psoriasis include IL-17 inhibitors (Cosentyx, Taltz, Bimzelx) and TNF inhibitors (with biosimilars now available for adalimumab and infliximab).

Warnings:

Important warnings include serious infections, tuberculosis (TB) reactivation, and hypersensitivity reactions. TB screening before therapy is part of standard care. Patients should not be vaccinated with live vaccines while on Tremfya. Tell your prescriber about any new fevers, persistent cough, or unusual symptoms.

FAQ (Frequently Asked Questions)

How Much Does Tremfya Cost Without Insurance?+

The average retail price runs approximately $13,000–$15,000 per dose. With every-8-week maintenance dosing, annual costs commonly reach $80,000+. Through AffordMyPrescriptions, qualifying patients receive Tremfya at no medication cost — our $69.95 monthly fee covers full advocacy and program management.

Tremfya is given as a 100 mg subcutaneous injection. For psoriasis: at Week 0, Week 4, then every 8 weeks. For PsA: same schedule, or 200 mg loading then maintenance. For UC and Crohn’s: IV induction followed by SC maintenance every 4 or 8 weeks. The injection can be self-administered at home after training.

Yes. Other IL-23 inhibitors include risankizumab (Skyrizi) and tildrakizumab (Ilumya). Other psoriasis biologics include IL-17 inhibitors (Cosentyx, Taltz, Bimzelx), IL-12/23 inhibitors (Stelara, with multiple biosimilars now available), and TNF inhibitors (Humira and Remicade with biosimilars). Whether one is a better fit depends on your indication, prior treatments, and tolerability.

Yes. Patients are typically screened for tuberculosis (latent and active) before starting Tremfya, since IL-23 inhibition can affect immune function. Your prescriber will also review your medical history, including any history of recurrent infections or vaccination needs.

If your initial application is denied, we explore alternatives — the manufacturer’s copay savings program if you have commercial insurance, independent foundations such as the National Psoriasis Foundation, Crohn’s & Colitis Foundation, PAN Foundation, or HealthWell Foundation, or asking your prescriber whether a Stelara biosimilar (significantly cheaper) or a different psoriasis biologic would be appropriate. If we cannot find a path, you will not becharged our service fee.

Yes. Medicare Part D beneficiaries can typically qualify for Tremfya Patient Assistance, especially if you face specialty-tier copays you cannot afford. The manufacturer’s commercial copay savings program is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.

Take Control of Your Medication Costs

If you are struggling with the high cost of Tremfya, our team may be able to help you access assistance programs designed to make brand specialty psoriasis biologics affordable. Check your eligibility today.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process